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draft genome sequence of Corynebacterium argentoratense strains isolated
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ONCE, Madrid, SpainAbstractDuring a 12-year period we isolated ﬁve Corynebacterium argentoratense strains identiﬁed by phenotypic methods, including the use of matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF) and 16S rRNA gene sequencing. In addition, antimicrobial
susceptibility was determined, and genome sequencing for the detection of antibiotic resistance genes was performed. The organisms were
isolated from blood and throat cultures and could be identiﬁed by all methods used. All strains were resistant to cotrimoxazole, and
resistance to β-lactams was partly present. Two strains were resistant to erythromycin and clindamycin. The draft genome sequences of
theses isolates revealed the presence of the erm(X) resistance gene that is embedded in the genetic structure of the transposable
element Tn5423. Although rarely reported as a human pathogen, C. argentoratense can be involved in bacteraemia and probably in other
infections. Our results also show that horizontal transfer of genes responsible for antibiotic resistance is occurring in this species.
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E-mail: ifernandeznatal@gmail.comIntroductionCorynebacterium argentoratense was described by Riegel et al. [1]
in 1995 after isolating this organism in Strasbourg, a city
formerly known as Argentoratum. The taxonomic description
of this new species was based on four strains isolated from
throat specimens of patients with tonsillitis. The bacterium is
nonlipophilic and has typical coryneform morphology, and thew Microbe and New Infect 2016; 10: 116–121
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p://dx.doi.org/10.1016/j.nmni.2016.01.007cell wall contains meso-diaminopimelic acid, arabinose, galac-
tose and mycolic acids of short chain lengths [1]. The whole
genome sequence of the type strain C. argentoratense DSM
44202 (IBS B10697) has a deduced size of 2 031 902 bp with an
average G+C content of 58.9%, revealing what is to date the
smallest chromosome of a corynebacterial species associated
with humans [2].
The same group of researchers from Strasbourg reported
the isolation of C. argentoratense from eight respiratory tract
specimens (seven from the upper respiratory tract and one
from the lower) and another one an ear specimen [3]. This
report probably includes the four isolates previously referred
to in the taxonomic description of C. argentoratense [1]. In
addition to these nine isolates, this organism has been isolated
from blood cultures of patients in Canada [4] and Saudi ArabiaEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Data on 21 published Corynebacterium
argentoratense isolates from human sources
Specimen
(n)
Geographical
source
Clinical
data Reference
Upper respiratory
tract (7)
Strasbourg,
France
Probably including
4 patients with
tonsillitis
[3]
Lower respiratory
tract (1)
Strasbourg,
France
Not reported [3]
Ear (1) Strasbourg,
France
Not reported [3]
Blood
culture (1)
Ontario,
Canada
Not reported [4]
Blood
culture (1)
Riyadh,
Saudi Arabia
Patient
with tonsillitis
[5]
Intravenous
sites (2)
Rio de Janeiro,
Brazil
Cancer patients [6]
Conjunctival
fornix (2)
US and/or
Asian clinical
sites
Patients with
bacterial conjunctivitis
[7]
Adenoid
tissue (1)
Leiden,
The Netherlands
Child with
otitis media
[8]
Pharyngeal (3) León,
Spain
3 patients
with pharyngitis
This study
Blood
culture (2)
León,
Spain
2 febrile patients
(upper respiratory tract
infection and
ischemic colitis)
This study
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tients [6], from the conjunctiva of patients with bacterial
conjunctivitis [7] and as part of a mucosal bioﬁlm in the adenoid
tissue of a child with otitis media [8]. Table 1 summarizes the
sources, geographical origins and clinical data of the
C. argentoratense isolates described so far.
Data on the natural habitat and the susceptibility of
C. argentoratense to antimicrobials are limited. Metadata of the
microbiota of 18 body sites in more than 200 individuals ob-
tained in the course of the Human Microbiome Project indi-
cated that C. argentoratense is mostly present in saliva and to a
lesser extent on the hard palate [9]. An additional study
including 19 gastritis patients with a typical greasy white or
dense yellow tongue coating revealed that C. argentoratense is
part of this characteristic tongue-coating microbiome [10]. The
in vitro susceptibility of C. argentoratense to eight antibiotics
(ampicillin, cefotaxime, ceftazidime, ciproﬂoxacin, erythro-
mycin, fusidic acid, gentamicin and rifampin) has been deter-
mined by the disk diffusion method for nine isolates [3]. Only
resistance to ceftazidime was broadly present (78%) in
C. argentoratense.
Here we present data on the origin of C. argentoratense
isolates, microbiologic proﬁles, including identiﬁcation by
matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF), and 16S rRNA gene sequencing,
as well as data on the minimum inhibitory concentrations for 28
antibiotics as determined by Etest. Moreover, draft genome
sequences of two erythromycin- and clindamycin-resistant
isolates are presented, leading to the detection of the erm(X)
resistance gene.Material and MethodsStrains
Two strains were isolated from blood cultures belonging to
two different patients, and three other strains were recovered
from throat specimens of three different patients with phar-
yngitis. All strains were obtained from patients who sought care
at a hospital in the north of Spain (Complejo Asistencial Uni-
versitario de León, León) from January 2003 to December
2014.
Phenotypic identiﬁcation
API Coryne 2.0 (bioMérieux, Marcy l’Etoile, France), API Strep
(hippurate hydrolysis), API NH (fructose fermentation) and API
NE (assimilation of maltose, N-acetyl-glucosamine and phenyl-
acetic acid) were used for the phenotypic characterization of
the corynebacterial isolates. In addition, catalase and oxidase
reactions, lipophilia, Christie Atkins Munch-Peterson (CAMP)New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf o
This is an open access artireaction, glucose fermentation at 42°C, growth on blood agar
at 20°C and susceptibility to vibriostatic factor O/129 were
tested following previously described methods [11].
MALDI-TOF was carried out with a Bruker Biotyper
MALDI-TOF system (Bruker Daltonics, Leipzig, Germany).
Software and library version 3.1 was used for the bacterial
identiﬁcation. The direct colony method, including spotting
onto a MALDI-TOF target plate covered with 1 μL of formic
acid (100%) and 1 μL of matrix, was performed as previously
described [12]. Scores of 1.5 and 1.7 were used for genus
and species identiﬁcation respectively [13].
Genotypic identiﬁcation
The ampliﬁcation of the 16S rRNA gene and the DNA
sequencing were performed according to previously described
methods [14].
Antimicrobial susceptibility
Antimicrobial susceptibility testing to 28 antimicrobials was
determined by Etest on Mueller-Hinton agar with 5% sheep’s
blood, incubated in air at 35°C and read after 48 hours. Sus-
ceptibility to antibiotics was interpreted following the 2014
recommended criteria for coryneform organisms [15].
Genome sequencing and search for antibiotic
resistance genes
Technical details of genome sequencing, assembly and annota-
tion of two antibiotic-resistant C. argentoratense isolates have
been announced previously [16]. Both genome sequences were
annotated using the RAST genome annotation server [17].f European Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 116–121
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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search for antibiotic resistance genes in the Antibiotic Resis-
tance Genes Database [18] and in published genome informa-
tion of Corynebacterium strains. Comparative genomic analysis
was performed with the EDGAR software [19]. All-against-all
comparisons were based on the BLASTP algorithm with the
standard scoring matrix BLOSUM62 and an initial E-value cutoff
of 1 × 10−5. The ﬁnal score ratio value was calculated and set to
32. Two genes were considered orthologous when revealing a
bidirectional best BLAST hit with a single score ratio value
exceeding the precalculated cutoff.
Nucleotide sequence accession numbers
The 16S rRNA gene sequences corresponding to the ﬁve iso-
lated strains have been deposited in the GenBank nucleotide
database under accession numbers KP230551 (CNM463/05),
KP230549 (CNM629/14), KP230548 (CNM630/14), KP230547
(CNM631/14) and KP230550 (CNM601/08).ResultsIsolation of C. argentoratense from clinical sources
C. argentoratense was obtained from a single blood culture in a
3-year-old boy with an upper respiratory tract infection (strain
CNM463/05) and from two blood cultures in an 85-year-old
woman with ischemic colitis and high fever (strain CNM601/
08). In three other patients, aged 7 months, 4 years and 50
years and with tonsillitis, C. argentoratense was isolated in mixed
culture with normal pharyngeal ﬂora (strains CNM629/14,
CNM630/14 and CNM631/14 respectively).
Species identiﬁcation by microbiologic and molecular
methods
Microbiologic and genetic methods and MALDI-TOF were used
to assign the ﬁve isolates to a corynebacterial species. All iso-
lates showed identical microbiologic phenotypic characteristics.
After 48 hours’ incubation in air at 35°C, colonies on blood
agar were nonhaemolytic, slightly rough and cream colored,
and 2 mm in diameter. All isolates presented the same API
proﬁles (2100104 at 24 hours and 2100304 at 48 hours), sug-
gesting C. argentoratense (79.2%, T = 1) or C. jeikeium (93.6%,
T = 1). The latter proﬁle was doubtful because the isolates
were nonlipophilic. Positive reactions were observed for cata-
lase, hippurate hydrolysis, pyrazinamidase and alkaline phos-
phatase. Acid was produced from glucose (24 hours), ribose
(48 hours) and fructose (4 hours) but not from mannitol, su-
crose, ribose, xylose, maltose, lactose and glycogen. On the
other hand, the organisms were oxidase negative, urease
negative and nitrate reductase negative. Negative reactionsNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licewere also observed for esculin and gelatine hydrolysis, for
β-glucuronidase, β-galactosidase, α-glucosidase and N-acetyl-
β-glucosaminidase activities, for the CAMP test and for the
assimilation of maltose, N-acetyl-glucosamine and phenylacetic
acid. The organisms grew on blood agar at 20°C and fermented
glucose at 42°C within 3 days. All isolates were inhibited by the
O/129 factor (150 μg) showing an inhibition diameter between
18 and 27 mm.
Using MALDI-TOF, as previously described, the isolates
were tested ﬁve times recording the two values given by the
system, so 50 score values were obtained ranging from 2.166 to
2.378 (mean, 2.293) and providing a reliable identiﬁcation of
C. argentoratense. For comparison, two C. jeikeium strains were
also studied ﬁve times with two readings, obtaining score values
ranging from 1.816 to 2.268 (mean, 1.965). The PCR fragments
of the 16S rRNA gene obtained were 1200 bp (CNM463/05),
1411 bp (CNM629/14), 1399 bp (CNM630/14), 1425 bp
(CNM631/14) and 1141 bp (CNM601/08) in length. The
nucleotide sequence similarities with the 16S rRNA gene of the
C. argentoratense type strain were in the range of 99.5 to 99.9%.
All data clearly demonstrated that the ﬁve isolates are members
of the species C. argentoratense.Antimicrobial susceptibility proﬁling of
C. argentoratense isolates
The antimicrobial susceptibility data for the ﬁve isolates tested
are presented in Table 2. Using the Etest method and applying
the recommendations of the Clinical and Laboratory Standards
Institute for antimicrobial susceptibility of coryneform organ-
isms [15], the new C. argentoratense isolates were uniformly
sensitive to vancomycin, linezolid, daptomycin, tetracycline,
ciproﬂoxacin, quinupristin/dalfopristin, gentamicin and rifampin.
Strain CNM631/14 showed very high minimum inhibitory
concentration (MIC) values of benzylpenicillin (>256 mg/L),
cefotaxime (8 mg/L) and imipenem (>32 mg/L), and MICs of
ceﬁxime were 64 mg/L for all isolates. All isolates were
resistant to cotrimoxazole. Two strains (CNM463/05 and
CNM601/08) were resistant to erythromycin and clindamycin.
Genome sequencing and search for antibiotic
resistance genes
To identify the genes responsible for the detected erythro-
mycin and clindamycin resistance of C. argentoratense, draft
genome sequences of CNM463/05 and CNM601/08 were
established [16]. Prominent features of the C. argentoratense
genomes and of those from taxonomically related cor-
ynebacteria are summarized in Table 3. Both C. argentoratense
isolates showed similar genome sizes of approximately 2.02
Mbp with a mean G+C content of 58.9% and similar numbers
of predicted genes. These data supported the previous resultEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 116–121
nses/by-nc-nd/4.0/)
TABLE 2. Antimicrobial susceptibility (MIC, mg/L) of ﬁve Corynebacterium argentoratense strains, isolated from bacteraemia
(strains 1 and 2) and pharyngotonsillitis (strains 3–5), to 28 antimicrobial agents
Antimicrobial agent Strain 1 (CNM463/05) Strain 2 (CNM601/08) Strain 3 (CNM629/14) Strain 4 (CNM630/14) Strain 5 (CNM631/14)
Benzylpenicillina 1.5 4 1.5 0.75b >256
Ampicillin 1.5 1.5 2 1 >256
Cefuroxime 3 2 2 1.5 4
Ceﬁxime > 256 >256 96 64 >256
Cefotaximea 3 4 2 1.5 8
Imipenema 0.75b 0.5b 0.75b 0.38b >32
Vancomycina 0.5b 0.75b 0.5b 0.5b 0.5b
Teicoplanin 1 1 1 0.5 1
Linezolida 0.38b 0.25b 0.5b 0.38b 0.38b
Daptomycina 0.016b 0.016b 0.016b <0.016b 0.032b
Tetracyclinea 0.5b 0.38b 0.25b 0.38b 0.5b
Tigecycline 0.64 0.023 0.094 0.094 0.094
Chloramphenicol 1.5 1 1 1 1
Ciproﬂoxacina 0.125b 0.25b 0.125b 0.125b 0.125b
Moxiﬂoxacin 0.047 0.064 0.064 0.064 0.064
Levoﬂoxacin 0.125 0.5 0.125 0.125 0.125
Erythromycina >256 12 <0.016b <0.016b <0.016b
Clarithomycin >256 16 0.016 0.016 0.016
Azithromycin >256 >256 0.125 0.094 0.125
Clindamycina >256 >256 0.094b 0.094b 0.094b
Quinupristin-dalfopristina 0.038b 0.094b 0.038b 0.038b 0.038b
Streptomycin 3 16 2 1 3
Kanamycin 12 64 8 4 12
Gentamicina 1.5b 1b 1.5b 1b 2b
Tobramycin 4 6 4 2 6
Amikacin 4 4 4 2 8
Rifampina 0.032b 0.023b 0.023b 0.023b 0.032b
Cotrimoxazolea >32 >32 >32 >32 >32
MIC, minimum inhibitory concentration.
aAntibiotics proposed for testing coryneform organisms.
bMIC values within the range of susceptibility (based on Clinical and Laboratory Standards Institute [15]).
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has the smallest genome of a corynebacterium associated with
humans [2]. The genomes of species assigned to the same
taxonomic clade as C. argentoratense are in the size range from
2.6 to 2.7 Mbp with a G+C content ranging from 58.1 to
68.6% (Table 3). These variations are indicative of the di-
versity of the genus Corynebacterium in terms of lifestyle and
habitat, including human, animal, terrestrial, marine and
technical environments [20]. The draft genome sequences of
both isolates revealed a high grade of similarity between them
(>99.9%) as well as with the genome sequence of the type
strain C. argentoratense DSM 44202 (>95.0%). A comparison
of the predicted proteomes with the EDGAR software
revealed that both clinical isolates and the type strain DSM
44202 share a common set of 1582 proteins. An all-against-all
comparison with the proteomes of four taxonomically related
species reduced this number to 1078 proteins that represent
the conserved core of this diverse clade.
The antibiotic resistance gene erm(X) coding for macrolide,
lincosamide and streptogramin B (MLSb) resistance was
detected in the genome of both isolates, CNM 463/05 and
CNM 601/08. This gene is absent in the genome of the type
strain DSM 44202. It was allocated to a speciﬁc genomic re-
gion with 100% similarity to the transposable element
Tn5432, initially found in the R-plasmid pTP10 of Corynebac-
terium striatum M82B [21,22], indicating the horizontalNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf o
This is an open access artitransfer of an antibiotic resistance region to the clinical strains
from human sources. Tn5432 is composed of two IS1249
sequences, the erm(X) gene and the transposase gene tnpCX
and was previously also detected in Corynebacterium ure-
alyticum [23], in Propionibacterium acnes [24] and in some
Biﬁdobacterium species [25,26].DiscussionThe pathogenicity of C. argentoratense in humans is not well
understood. Two cases of bacteraemia by this organism have
been reported previously, one in a patient with tonsillitis [5]
and another from a patient in whom no clinical data were
provided [4]. Here we add two additional cases of bacteraemia,
one of them in a patient from whom the organism was isolated
from two different blood cultures.
Although C. argentoratense is not presently recognized as a
cause of pharyngotonsillitis, this organism has been isolated
from seven patients with tonsillitis [1] (present study); its
possible role in this condition thus merits further study.
Moreover, if this organism is responsible for pharyngotonsillitis,
and if patients are to be empirically treated with penicillins
based on a suspicion of a Streptococcus pyogenes infection, such a
treatment could be ineffective in some cases, as inferred by the
antimicrobial susceptibility data obtained in this study. Thef European Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 116–121
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
TABLE 3. Features of Corynebacterium argentoratense genomes and taxonomically related species
Corynebacterium species Strain Source
Genome
No. of genes Pseudogenes No. of proteins GenBank IDStatus Size (bp) G+C%
C. argentoratense DSM 44202 Human; respiratory tract Complete 2031902 58.9 1890 55 1772 CP006365
C. argentoratense CNM 463/05 Human; respiratory tract Draft 2020912 58.9 1871 Not applicable 1643 JZEZ00000000
C. argentoratense CNM 601/08 Human; blood Draft 2014822 58.9 1878 Not applicable 1656 JZFA00000000
C. epidermidicanis DSM 45586 Dog; skin Complete 2692072 58.1 2541 Not detected 2465 CP011541
C. humireducens DSM 45392 Microbial fuel cell Complete 2681312 68.6 2595 46 2482 CP005286
C. marinum DSM 44953 Coastal sediment Complete 2607268 68.1 2457 50 2341 CP007790
C. testudinoris DSM 44614 Tortoise; mouth Complete 2721226 63.1 2590 40 2485 CP011545
120 New Microbes and New Infections, Volume 10 Number C, March 2016 NMNIisolation of C. argentoratense from intravenous sites in patients
with cancer [6] and from the conjunctival fornix in patients with
conjunctivitis [7] is of interest and also merits further
investigation.
C. argentoratense is a nonlipophilic, fermentative, nitrate
reductase-, urease- and oxidase-negative corynebacterium
producing acid from glucose but not from maltose and sucrose
[20]. It can be identiﬁed by API-Coryne, and some additional
biochemical tests may be of great help for a phenotypic iden-
tiﬁcation. MALDI-TOF scores of 2.166 were obtained for the
ﬁve isolates, which can be considered as reliable values for a
signiﬁcant species identiﬁcation [13]. To our knowledge, there
is just one published article reporting the identiﬁcation of two
C. argentoratense isolates by MALDI-TOF [27]. As occurs with
many other Corynebacterium species, 16S rRNA sequencing was
also a useful tool to identify C. argentoratense [20].
The antimicrobial susceptibility of nine C. argentoratense
strains, isolated between 1995 and 1996, has been determined
by a disk diffusion method [3]. Using the interpretative cate-
gories recommended by the Antibiogram Committee of the
French Society for Microbiology [28], the organisms were
considered to be fully sensitive to ampicillin, cefotaxime, fusidic
acid and rifampin. Only one of nine isolates was resistant to
erythromycin and ciproﬂoxacin [3]. This unusual pattern of
antimicrobial susceptibility, described approximately 15 years
ago, agrees with the lack of typical corynebacterial antibiotics
resistance genes in the genome of the type strain of
C. argentoratense [2]. In our strains, isolated from 2003 to 2014,
resistance to β-lactams, erythromycin and clindamycin was
found. One isolate (CNM631/14) presented high MIC values for
penicillins and cephalosporins. Isolate CNM463/05 was highly
resistant to erythromycin and clindamycin, and isolate
CNM601/08 was moderately resistant to erythromycin and
highly resistant to clindamycin. Resistance to erythromycin,
clindamycin and other MLSb antibiotics is often associated with
the presence of the erm(X) gene in corynebacteria [20].
Interestingly, CNM463/05 and CNM601/08 presented the
MLSb resistance gene erm(X), located in the speciﬁc transposon
Tn5432 previously described in C. striatum [22], as well asNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceC. urealyticum [23] and in the other actinobacterial genera Pro-
pionibacterium [24] and Biﬁdobacterium [25,26].
In summary, further studies on the pathogenicity, habitat and
epidemiology of C. argentoratense should be carried out,
including investigation of its possible role as a cause of phar-
yngotonsillitis. Moreover, as observed in a growing number of
members of the Corynebacterium genus [20], it seems that
horizontal transfer of genes responsible for antibiotic resistance
is occurring in this species, which will in future make the
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